NHS Agenda for Change staff in England are in line for a 3.6% pay rise, backdated to April 2025. This increase, matching the current rate of inflation, has sparked criticism from unions over its delayed rollout and lack of support for the lowest paid. The move impacts hundreds of thousands across the health sector, from nurses to clerical staff.

Joe Biden, 82, has been diagnosed with aggressive prostate cancer that’s spread to his bones, bringing renewed focus to men’s health and cancer awareness. Now facing complex treatment choices, Biden joins millions of men battling the disease, as leaders and citizens nationwide show support.

Scotland has put forward a two-year pay deal for NHS nurses and other Agenda for Change staff, featuring rises tied to inflation and a minimum increase of 4.25% in 2025, followed by 3.75% in 2026. The £701 million offer impacts 170,000 health staff and comes as unions seek feedback from their members.

Capivasertib, a pioneering AKT inhibitor from AstraZeneca and Astex Pharmaceuticals, has received UK approval for HR+/HER2- breast cancer with specific genetic alterations. This marks a significant advancement following its recent FDA approval. Demonstrating a substantial reduction in disease progression, Capivasertib is poised to redefine options for patients, highlighting renewed focus on AKT inhibitors in cancer therapy.